These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 6778956

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Inhibition by apomorphine of the potassium-evoked release of [3H]-gamma-aminobutyric acid from the rat substantia nigra in vitro.
    Arbilla S, Kamal LA, Langer SZ.
    Br J Pharmacol; 1981 Oct; 74(2):389-97. PubMed ID: 7317688
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Function of nigral dopamine receptors?
    Glick SD, Crane LA.
    Brain Res; 1978 Nov 10; 156(2):380-1. PubMed ID: 568507
    [No Abstract] [Full Text] [Related]

  • 6. Effect of dopamine agonists on gamma-aminobutyric acid (GABA) turnover in the superior colliculus: evidence that nigrotectal GABA projections are under the influence of dopaminergic transmission.
    Melis MR, Gale K.
    J Pharmacol Exp Ther; 1983 Aug 10; 226(2):425-31. PubMed ID: 6875856
    [Abstract] [Full Text] [Related]

  • 7. Regulation of GABA release by dopamine in the rat substantia nigra.
    Reubi JC, Iversen LL, Jessell TM.
    Adv Biochem Psychopharmacol; 1978 Aug 10; 19():401-4. PubMed ID: 696468
    [No Abstract] [Full Text] [Related]

  • 8. Comparative effects of chronic haloperidol and sulpiride treatment on nigral and striatal GABA content.
    Nicoletti F, Patti F, Condorelli DF, Rampello L, Giammona G, Di Giorgio RM, Canonico PL, Scapagnini U.
    J Neurochem; 1981 Oct 10; 37(4):1048-51. PubMed ID: 7320718
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Dopaminergic receptor activity in substantia nigra in the mechanisms of autoregulation of striatal dopamine release.
    Groppetti A, Parenti M, Cattabeni F, Maggi A, De Angelis L, Monduzzi M, Racagni G.
    Adv Biochem Psychopharmacol; 1978 Oct 10; 19():363-71. PubMed ID: 696464
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Dopamine selectively increases 3H-GABA release from slices of rat substantia nigra in vitro.
    Reubi JC, Iversen LL, Jessell TM.
    Nature; 1977 Aug 18; 268(5621):652-4. PubMed ID: 197423
    [No Abstract] [Full Text] [Related]

  • 14. Distribution and release of GABA in the basal ganglia.
    Korf J, van der Heyden JA, Venema K, Postema F.
    Adv Biochem Psychopharmacol; 1981 Aug 18; 30():105-17. PubMed ID: 7331934
    [No Abstract] [Full Text] [Related]

  • 15. Chronic blockade of dopamine receptors by antischizophrenic drugs enhances GABA binding in substantia nigra.
    Gale K.
    Nature; 1980 Feb 07; 283(5747):569-70. PubMed ID: 7354838
    [No Abstract] [Full Text] [Related]

  • 16. Pertussis toxin blocks autoreceptor-mediated inhibition of dopaminergic neurons in rat substantia nigra.
    Innis RB, Aghajanian GK.
    Brain Res; 1987 May 12; 411(1):139-43. PubMed ID: 2955848
    [Abstract] [Full Text] [Related]

  • 17. In vivo release of endogenous GABA from rat striatum: inhibition by dopamine.
    van der Heyden JA, Venema K, Korf J.
    J Neurochem; 1980 May 12; 34(5):1338-41. PubMed ID: 7373314
    [No Abstract] [Full Text] [Related]

  • 18. Apomorphine-induced inhibition of striatal dopamine release: role of dopaminergic receptors in substantia nigra.
    Maggi A, Bruno F, Cattabeni F, Groppetti A, Parenti M, Racagni G.
    Brain Res; 1978 Apr 21; 145(1):180-4. PubMed ID: 205324
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.